7/12/2022Youtube Video: Layoff Triggered in China's Pharma as Beijing Continues...

7/1/2022Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...

6/28/2022NMPA Issues Notice to Further Strengthen Services to Foreign-Invested ...

6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...

6/21/2022AstraZeneca to Open New Regional Headquarters in Qingdao

6/16/2022Pharma Downplays Challenges, Seeing Innovation Instead (Biospace)

6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs

6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...

6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...

6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...

6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021

6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031

5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021

5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)

5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021

5/20/2022U.S., European Firms Rethink China Investment After Lockdowns

5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...

5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021

5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

4/26/2022AstraZeneca Remain Bullish on Long-term Development in China

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

Page:7/36 Total number of articles:1059: [First][<<] [5] [6] [7] [8] [9] [>>] [End]